Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA*

OBJECTIVES: All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe. METHODS: EuroSIDA patients with viraemic HCV infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Grint, D, Peters, L, Schwarze-Zander, C, Beniowski, M, Pradier, C, Battegay, M, Jevtovic, D, Soriano, V, Lundgren, JD, Rockstroh, JK, Kirk, O, Mocroft, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030620/
https://www.ncbi.nlm.nih.gov/pubmed/23869664
http://dx.doi.org/10.1111/hiv.12068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030620/
https://www.ncbi.nlm.nih.gov/pubmed/23869664
http://dx.doi.org/10.1111/hiv.12068

Ejemplares similares